Synapse - Works

Results (115783)

Molecular correlates of PD-L1 expression in patients with non-small cell lung cancer

Meeting Abstract

Rizvi, H.; Bandlamudi, C.; Schoenfeld, A. J.; Sauter, J. L.; Arbour, K. C.; Beras, A.; Egger, J. V.; Ladanyi, M.; Donoghue, M.; Rudin, C. M.; more...
Journal of Clinical Oncology (2019)

Fulltext@MSK | Save

Phase 1/1B trial to assess the activity of entrectinib in children and adolescents with recurrent or refractory solid tumors including central nervous system (CNS) tumors

Meeting Abstract

Robinson, G. W.; Gajjar, A. J.; Gauvain, K. M.; Basu, E. M.; Macy, M. E.; Maese, L. D.; Sabnis, A. J.; Foster, J. H.; Shusterman, S.; Yoon, J.; more...
Journal of Clinical Oncology (2019)

Fulltext@MSK | Save

Ivosidenib (IVO; AG-120) in IDH1-mutant newly-diagnosed acute myeloid leukemia (ND AML): Updated results from a phase 1 study

Meeting Abstract

Roboz, G. J.; Dinardo, C. D.; Stein, E. M.; de Botton, S.; Mims, A. S.; Prince, G. T.; Altman, J. K.; Arellano, M. L.; Erba, H. P.; Pollyea, D. A.; more...
Journal of Clinical Oncology (2019)

Fulltext@MSK | Save

Blocking LILRB and KIR receptors by B57 open conformers induces potent antitumor activity and acts synergistically with checkpoint blockade inhibition

Meeting Abstract

Renner, C.; Curran, M. A.; Kolibaba, J.; Liu, Y.; Petrausch, U.; Zippelius, A.; Stenner, F.; Rafiei, A.; Belaunzaran, O. M.
Journal of Clinical Oncology (2019)

Fulltext@MSK | Save

Neoadjuvant nivolumab in resectable non-small cell lung cancer: Extended follow-up and molecular markers of response

Meeting Abstract

Reuss, J. E.; Smith, K. N.; Anagnostou, V.; Zhang, J.; Zahurak, M.; Caushi, J.; Chan, H. Y.; Guo, H.; Hellmann, M. D.; Pardoll, D. M.; more...
Journal of Clinical Oncology (2019)

Fulltext@MSK | Save

Real-world utilization of EGFR TKI therapies and treatment outcomes in patients with advanced EGFR-sensitizing mutation-positive NSCLC

Meeting Abstract

Riely, G. J.; Lovly, C. M.; Messina, C. G. M.; Bienert, S.; Alexander, K.; Pao, W.; Baxi, S.; Doebele, R. C.
Journal of Clinical Oncology (2019)

Fulltext@MSK | Save

Atezolizumab (atezo) plus bevacizumab (bev) versus sunitinib (sun) in pts with untreated metastatic renal cell carcinoma (mRCC) and sarcomatoid (sarc) histology: IMmotion151 subgroup analysis

Meeting Abstract

Rini, B. I.; Motzer, R. J.; Powles, T.; McDermott, D. F.; Escudier, B.; Donskov, F.; Hawkins, R. E.; Bracarda, S.; Bedke, J.; De Giorgi, U.; more...
Journal of Clinical Oncology (2019)

Fulltext@MSK | Save

Molecular profiling of ER plus metastatic breast cancers to reveal association of genomic alterations with acquired resistance to CDK4/6 inhibitors

Meeting Abstract

Razavi, P.; dos Anjos, C. H.; Brown, D. N.; Qing, L.; Ping, C.; Herbert, J.; Colon, J.; Liu, D.; Mao, M.; Norton, L.; more...
Journal of Clinical Oncology (2019)

Fulltext@MSK | Save

Variation in the surgical management of locally advanced pancreatic cancer

Meeting Abstract

Reames, B. N.; Blair, A.; Krell, R. W.; Padussis, J.; Thayer, S. P.; Falconi, M.; Wolfgang, C. L.; Weiss, M. J.; Are, C.; He, J.
Journal of Clinical Oncology (2019)

Fulltext@MSK | Save

Phase II study to evaluate safety and efficacy of MEDI4736 (durvalumab) plus radiotherapy in patients with newly diagnosed unmethylated MGMT glioblastoma (new unmeth GBM)

Meeting Abstract

Reardon, D. A.; Kaley, T. J.; Dietrich, J.; Clarke, J. L.; Dunn, G.; Lim, M.; Cloughesy, T. F.; Gan, H. K.; Park, A. J.; Schwarzenberger, P.; more...
Journal of Clinical Oncology (2019)

Fulltext@MSK | Save